Diffuse large B-cell lymphoma: New guidelines include MYC The Oncology Report ... 70% of cells on immunohistochemistry (which equates to a "double-hit score" of 2) confers a far worse outcome than a score of 0 or 1 in patients with DLBCL undergoing R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone), he said. |
